1
|
Xie X, Zhai J, Zhou X, Guo Z, Lo PC, Zhu G, Chan KWY, Yang M. Magnetic Particle Imaging: From Tracer Design to Biomedical Applications in Vasculature Abnormality. ADVANCED MATERIALS (DEERFIELD BEACH, FLA.) 2024; 36:e2306450. [PMID: 37812831 DOI: 10.1002/adma.202306450] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/03/2023] [Revised: 09/14/2023] [Indexed: 10/11/2023]
Abstract
Magnetic particle imaging (MPI) is an emerging non-invasive tomographic technique based on the response of magnetic nanoparticles (MNPs) to oscillating drive fields at the center of a static magnetic gradient. In contrast to magnetic resonance imaging (MRI), which is driven by uniform magnetic fields and projects the anatomic information of the subjects, MPI directly tracks and quantifies MNPs in vivo without background signals. Moreover, it does not require radioactive tracers and has no limitations on imaging depth. This article first introduces the basic principles of MPI and important features of MNPs for imaging sensitivity, spatial resolution, and targeted biodistribution. The latest research aiming to optimize the performance of MPI tracers is reviewed based on their material composition, physical properties, and surface modifications. While the unique advantages of MPI have led to a series of promising biomedical applications, recent development of MPI in investigating vascular abnormalities in cardiovascular and cerebrovascular systems, and cancer are also discussed. Finally, recent progress and challenges in the clinical translation of MPI are discussed to provide possible directions for future research and development.
Collapse
Affiliation(s)
- Xulin Xie
- Department of Precision Diagnostic and Therapeutic Technology, City University of Hong Kong Shenzhen Futian Research Institute, Shenzhen, 518057, China
- Department of Biomedical Sciences, and Tung Biomedical Sciences Centre, City University of Hong Kong, 83 Tat Chee Avenue, Kowloon, Hong Kong SAR, 999077, China
| | - Jiao Zhai
- Department of Precision Diagnostic and Therapeutic Technology, City University of Hong Kong Shenzhen Futian Research Institute, Shenzhen, 518057, China
- Department of Biomedical Sciences, and Tung Biomedical Sciences Centre, City University of Hong Kong, 83 Tat Chee Avenue, Kowloon, Hong Kong SAR, 999077, China
| | - Xiaoyu Zhou
- Department of Precision Diagnostic and Therapeutic Technology, City University of Hong Kong Shenzhen Futian Research Institute, Shenzhen, 518057, China
- Department of Biomedical Sciences, and Tung Biomedical Sciences Centre, City University of Hong Kong, 83 Tat Chee Avenue, Kowloon, Hong Kong SAR, 999077, China
| | - Zhengjun Guo
- Department of Biomedical Sciences, and Tung Biomedical Sciences Centre, City University of Hong Kong, 83 Tat Chee Avenue, Kowloon, Hong Kong SAR, 999077, China
- Department of Oncology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, China
| | - Pui-Chi Lo
- Department of Precision Diagnostic and Therapeutic Technology, City University of Hong Kong Shenzhen Futian Research Institute, Shenzhen, 518057, China
- Department of Biomedical Sciences, and Tung Biomedical Sciences Centre, City University of Hong Kong, 83 Tat Chee Avenue, Kowloon, Hong Kong SAR, 999077, China
| | - Guangyu Zhu
- Department of Chemistry, City University of Hong Kong, Hong Kong SAR, 999077, China
| | - Kannie W Y Chan
- Department of Biomedical Engineering, City University of Hong Kong, Hong Kong SAR, 999077, China
| | - Mengsu Yang
- Department of Precision Diagnostic and Therapeutic Technology, City University of Hong Kong Shenzhen Futian Research Institute, Shenzhen, 518057, China
- Department of Biomedical Sciences, and Tung Biomedical Sciences Centre, City University of Hong Kong, 83 Tat Chee Avenue, Kowloon, Hong Kong SAR, 999077, China
| |
Collapse
|
2
|
Rendón-Medina MA, Garcia-Gonzalez I, Rojas-Ortiz JA, Hanson-Viana E, Mendoza-Vélez MDLÁ, Vargas Rocha JM, Hernández-Ordoñez R, Vazquez Morales HL, Sandoval-Rodriguez JI, Pacheco Lopez RC. Equivalence in Color-coded Duplex Sonography Parameters before Complex Microsurgery. PLASTIC AND RECONSTRUCTIVE SURGERY-GLOBAL OPEN 2023; 11:e5399. [PMID: 38025631 PMCID: PMC10653567 DOI: 10.1097/gox.0000000000005399] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2022] [Accepted: 09/26/2023] [Indexed: 12/01/2023]
Abstract
Background Color-coded duplex sonography (CCDS) is a widely proposed noninvasive diagnostic tool in microsurgery. CCDS has been applied to lower extremity salvage cases to define appropriate blood flow velocity criteria for achieving arterial success in diabetic foot and complex microsurgery cases. This study aimed to compare the success ratio of free flaps when using CCDS versus cases where CCDS was not used. Methods We included complex microsurgery cases from 2019 to 2021. These cases were subsequently categorized into two groups: group A consisted of cases where CCDS parameters were applied, whereas group B comprised cases where CCDS was not performed at all. Results The study encompassed 14 cases (11 men and three women). The age range varied from 23 to 62 years, with an average age of 42. Using CCDS analysis and planning demonstrated improved outcomes in comparison with cases where CCDS was not performed, albeit without statistical significance (P = 0.064). Conclusions The application of CCDS proves to be beneficial in the realm of microsurgery. Although not achieving statistical significance, our data imply that CCDS utilization holds promise for enhancing microsurgical procedures.
Collapse
|
3
|
Magnetic Particle Imaging in Vascular Imaging, Immunotherapy, Cell Tracking, and Noninvasive Diagnosis. Mol Imaging 2023. [DOI: 10.1155/2023/4131117] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/17/2023] Open
Abstract
Magnetic particle imaging (MPI) is a new tracer-based imaging modality that is useful in diagnosing various pathophysiology related to the vascular system and for sensitive tracking of cytotherapies. MPI uses nonradioactive and easily assimilated nanometer-sized iron oxide particles as tracers. MPI images the nonlinear Langevin behavior of the iron oxide particles and has allowed for the sensitive detection of iron oxide-labeled therapeutic cells in the body. This review will provide an overview of MPI technology, the tracer, and its use in vascular imaging and cytotherapies using molecular targets.
Collapse
|
4
|
Pantke D, Mueller F, Reinartz S, Philipps J, Mohammadali Dadfar S, Peters M, Franke J, Schrank F, Kiessling F, Schulz V. Frequency-selective signal enhancement by a passive dual coil resonator for magnetic particle imaging. Phys Med Biol 2022; 67. [PMID: 35472698 DOI: 10.1088/1361-6560/ac6a9f] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2021] [Accepted: 04/26/2022] [Indexed: 11/12/2022]
Abstract
Objective.Magnetic particle imaging (MPI) visualizes the spatial distribution of magnetic nanoparticles. MPI already provides excellent temporal and good spatial resolution, however, to achieve translation into clinics, further advances in the fields of sensitivity, image reconstruction and tracer performance are needed. In this work, we propose a novel concept to enhance the MPI signal and image resolution by a purely passive receive coil insert for a preclinical MPI system.Approach.The passive dual coil resonator (pDCR) provides frequency-selective signal enhancement. This is enabled by the adaptable resonance frequency of the pDCR network, which is galvanically isolated from the MPI system and composed of two coaxial solenoids connected via a capacitor. The pDCR aims to enhance frequency components related to high mixing orders, which are crucial to achieve high spatial resolution.Main Results.In this study, system matrix measurements and image acquisitions of a resolution phantom are carried out to evaluate the performance of the pDCR compared to the integrated receive unit of the preclinical MPI and a dedicated rat-sized receive coil. Frequency-selective signal increase and spatial resolution enhancement are demonstrated.Significance.Common dedicated receive coils come along with noise-matched receive networks, which makes them costly and difficult to reproduce. The presented pDCR is a purely passive coil insert that gets along without any additional receive electronics. Therefore, it is cost-efficient, easy-to-handle and adaptable to other MPI scanners and potentially other applications providing the basis for a new breed of passive MPI receiver systems.
Collapse
Affiliation(s)
- Dennis Pantke
- Department of Physics of Molecular Imaging, Institute for Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany
| | - Florian Mueller
- Department of Physics of Molecular Imaging, Institute for Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany
| | - Sebastian Reinartz
- Department of Diagnostic and Interventional Radiology, Uniklinik RWTH Aachen, Aachen, Germany
| | - Jonas Philipps
- Department of Physics of Molecular Imaging, Institute for Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany
| | - Seyed Mohammadali Dadfar
- Institute for Experimental Molecular Imaging, Medical Faculty, RWTH Aachen University, Aachen, Germany
| | - Maximilian Peters
- Department of Physics of Molecular Imaging, Institute for Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany
| | - Jochen Franke
- Department of Physics of Molecular Imaging, Institute for Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany.,Bruker BioSpin MRI GmbH, Preclinical Imaging Division, Ettlingen, Germany
| | - Franziska Schrank
- Department of Physics of Molecular Imaging, Institute for Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany
| | - Fabian Kiessling
- Institute for Experimental Molecular Imaging, Medical Faculty, RWTH Aachen University, Aachen, Germany.,Fraunhofer Institute for Digital Medicine MEVIS, Bremen, Germany
| | - Volkmar Schulz
- Department of Physics of Molecular Imaging, Institute for Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany.,Fraunhofer Institute for Digital Medicine MEVIS, Bremen, Germany.,III. Physikalisches Institut B, RWTH Aachen University, Aachen, Germany
| |
Collapse
|